http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101951948-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-085 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-1271 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-085 |
| filingDate | 2008-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2015-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-101951948-B |
| titleOfInvention | Ia method and composition is carried out with for staphylococcic pulmonary disease and disease |
| abstract | Embodiment of the present invention comprise the method and composition that can be used for vaccination strategies, described vaccination strategies can in and Hla to provide the immunoprotection for staphylococcus aureus property pneumonia.In certain aspects; the present invention includes with recombinant mutant form Hla (HlaH35L; wherein 35 hyte propylhomoserins become leucine) Hla that reduces for the toxicity of representative, it can be used for stoping the productivity of this toxin to be assembled and provides the protection for staphylococcus pneumonia for experimenter. |
| priorityDate | 2007-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1284.